<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-6C73XCFW/1fbe9d3e-7aa4-435c-be3b-ce1fe9d7a09b/PDF"><dcterms:extent>135 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-6C73XCFW/24aae3b4-0951-417e-89ca-5ac27da2f110/TEXT"><dcterms:extent>39 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1994-2025"><edm:begin xml:lang="en">1994</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:DOC-6C73XCFW"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-46R7GGHL" /><dcterms:issued>2008</dcterms:issued><dc:creator>Bunc, Matjaž</dc:creator><dc:creator>Šušteršič, Matjaž</dc:creator><dc:format xml:lang="sl">številka:4</dc:format><dc:format xml:lang="sl">letnik:47</dc:format><dc:format xml:lang="sl">str. 379-390</dc:format><dc:identifier>ISSN:0025-8121</dc:identifier><dc:identifier>COBISSID:25579225</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-6C73XCFW</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Medicinski razgledi</dc:publisher><dcterms:isPartOf xml:lang="sl">Medicinski razgledi</dcterms:isPartOf><dc:subject xml:lang="sl">Aldosteron</dc:subject><dc:subject xml:lang="en">Aldosterone</dc:subject><dc:subject xml:lang="en">Angiotensin-Converting Enzyme Inhibitors</dc:subject><dc:subject xml:lang="en">Angiotensins</dc:subject><dc:subject xml:lang="sl">Angiotenzini</dc:subject><dc:subject xml:lang="sl">Angiotenzin-pretvorba, encimski inhibitorji</dc:subject><dc:subject xml:lang="en">Antagonists And Inhibitors</dc:subject><dc:subject xml:lang="sl">arterijska hipertenzija</dc:subject><dc:subject xml:lang="sl">encimski inhibitorji</dc:subject><dc:subject xml:lang="sl">fiziologija</dc:subject><dc:subject xml:lang="sl">Hipertenzija</dc:subject><dc:subject xml:lang="sl">hormonski sistem</dc:subject><dc:subject xml:lang="en">Hypertension</dc:subject><dc:subject xml:lang="sl">kardiologija</dc:subject><dc:subject xml:lang="sl">Receptorji mineralokortikoidni</dc:subject><dc:subject xml:lang="sl">Receptorji, angiotenzin</dc:subject><dc:subject xml:lang="en">Receptors, Angiotensin</dc:subject><dc:subject xml:lang="en">Receptors, Mineralocorticoid</dc:subject><dc:subject xml:lang="en">Renin-Angiotensin System</dc:subject><dc:subject xml:lang="sl">Renin-angiotenzin, sistem</dc:subject><dc:subject rdf:resource="http://www.wikidata.org/entity/Q898218" /><dcterms:temporal rdf:resource="1994-2025" /><dc:title xml:lang="sl">Nova spoznanja o reninsko-angiotenzisko-aldosteronskem sistemu in nove strategije njegove zavore| New knowledge of renin-angiotensin-aldosterone system and new strategies of its blockade|</dc:title><dc:description xml:lang="sl">The renin-angiotensin-aldosterone system is a hormone system chat is vital forthe regulation of arterial blood pressure, electrolyte balance and extracellular fluid volume in the body. Since the discovery of renin in 1898 and later the renin-angiotensin-aldostcronc system, there have been numerous studies on its effects and influences on physiological and pathophysiological mechanisms in different organs. The classical renin-angiotensin-aldosterone system pathway that begins with the release of renin from the kidneys, throughangiotensin-I, angiotensin-II and aldosteroneformation is a widely known concept that could now be described as incomplete. There is increasing evidence of the existence of a tissue renin-angiotensin-aldosterone system butit has been unsatisfactorily blocked with the blocking strategies known to dace. The objective of this paper is to address new knowledge about the renin-angiotensin-aldosterone system and new strategies for its blockage</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:DOC-6C73XCFW"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:DOC-6C73XCFW" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:DOC-6C73XCFW/1fbe9d3e-7aa4-435c-be3b-ce1fe9d7a09b/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo Medicinski razgledi</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:DOC-6C73XCFW/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:DOC-6C73XCFW" /></ore:Aggregation></rdf:RDF>